These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 8534611

  • 21. Cyclosporine, FK506, mycophenolate mofetil, and prednisolone differentially modulate cytokine gene expression in human airway-derived epithelial cells.
    Borger P, Kauffman HF, Timmerman JA, Scholma J, van den Berg JW, Koëter GH.
    Transplantation; 2000 Apr 15; 69(7):1408-13. PubMed ID: 10798763
    [Abstract] [Full Text] [Related]

  • 22. FK506 and cyclosporin A inhibit stem cell factor-dependent cell proliferation/survival, while inducing upregulation of c-kit expression in cells of the mast cell line MC/9.
    Ito F, Toyota N, Sakai H, Takahashi H, Iizuka H.
    Arch Dermatol Res; 1999 May 15; 291(5):275-83. PubMed ID: 10367710
    [Abstract] [Full Text] [Related]

  • 23. Differential inhibition of cutaneous T-cell-mediated reactions and epidermal cell proliferation by cyclosporin A, FK-506, and rapamycin.
    Duncan JI.
    J Invest Dermatol; 1994 Jan 15; 102(1):84-8. PubMed ID: 7507155
    [Abstract] [Full Text] [Related]

  • 24. Cytokine induction as a measure of cutaneous toxicity in primary and immortalized porcine keratinocytes exposed to jet fuels, and their relationship to normal human epidermal keratinocytes.
    Allen DG, Riviere JE, Monteiro-Riviere NA.
    Toxicol Lett; 2001 Mar 08; 119(3):209-17. PubMed ID: 11246174
    [Abstract] [Full Text] [Related]

  • 25. Tacrolimus and cyclosporine A inhibit allostimulatory capacity and cytokine production of human myeloid dendritic cells.
    Szabo G, Gavala C, Mandrekar P.
    J Investig Med; 2001 Sep 08; 49(5):442-9. PubMed ID: 11523700
    [Abstract] [Full Text] [Related]

  • 26. FK506 and cyclosporin A inhibit granulocyte/macrophage colony-stimulating factor production by mononuclear cells in asthma.
    Sano T, Nakamura Y, Matsunaga Y, Takahashi T, Azuma M, Okano Y, Shimizu E, Ogushi F, Sone S, Ogura T.
    Eur Respir J; 1995 Sep 08; 8(9):1473-8. PubMed ID: 8575571
    [Abstract] [Full Text] [Related]

  • 27. FK506 (tacrolimus) inhibition of intracellular production and enhancement of interleukin 1alpha through glucocorticoid application to chemically treated human keratinocytes.
    Horiuchi Y, Bae SJ, Katayama I.
    Skin Pharmacol Physiol; 2005 Sep 08; 18(5):241-6. PubMed ID: 16015023
    [Abstract] [Full Text] [Related]

  • 28. Differences in responses of interleukin-1 and tumor necrosis factor alpha production and secretion to cyclosporin-A and ultraviolet B-irradiation by normal and transformed keratinocyte cultures.
    Marionnet AV, Chardonnet Y, Viac J, Schmitt D.
    Exp Dermatol; 1997 Feb 08; 6(1):22-8. PubMed ID: 9067703
    [Abstract] [Full Text] [Related]

  • 29. Effects of cyclosporin A and FK506 on Fc epsilon receptor type I-initiated increases in cytokine mRNA in mouse bone marrow-derived progenitor mast cells: resistance to FK506 is associated with a deficiency in FK506-binding protein FKBP12.
    Kaye RE, Fruman DA, Bierer BE, Albers MW, Zydowsky LD, Ho SI, Jin YJ, Castells MC, Schreiber SL, Walsh CT.
    Proc Natl Acad Sci U S A; 1992 Sep 15; 89(18):8542-6. PubMed ID: 1382293
    [Abstract] [Full Text] [Related]

  • 30. Response of normal human keratinocytes to sulfur mustard (HD): cytokine release using a non-enzymatic detachment procedure.
    Arroyo CM, Schafer RJ, Kurt EM, Broomfield CA, Carmichael AJ.
    Hum Exp Toxicol; 1999 Jan 15; 18(1):1-11. PubMed ID: 10025362
    [Abstract] [Full Text] [Related]

  • 31. Cyclosporin A enhances interleukin-8 expression by inducing activator protein-1 in human aortic smooth muscle cells.
    Murakami R, Kambe F, Mitsuyama H, Okumura K, Murohara T, Niwata S, Yamamoto R, Seo H.
    Arterioscler Thromb Vasc Biol; 2003 Nov 01; 23(11):2034-40. PubMed ID: 12958044
    [Abstract] [Full Text] [Related]

  • 32. Topical FK506--clinical potential or laboratory curiosity?
    Lauerma AI, Maibach HI.
    Dermatology; 1994 Nov 01; 188(3):173-6. PubMed ID: 7514460
    [Abstract] [Full Text] [Related]

  • 33. Molecular and biological actions of cyclosporin A and FK506 on T cell development and function.
    Holländer GA, Bierer BE, Burakoff SJ.
    Transfus Sci; 1994 Sep 01; 15(3):207-20. PubMed ID: 10155542
    [Abstract] [Full Text] [Related]

  • 34. Antilymphocytic activity of erythromycin distinct from that of FK506 or cyclosporin A.
    Keicho N, Kudoh S, Yotsumoto H, Akagawa KS.
    J Antibiot (Tokyo); 1993 Sep 01; 46(9):1406-13. PubMed ID: 7693639
    [Abstract] [Full Text] [Related]

  • 35. Regulatory effects of antipsoriatic agents on interleukin-1 alpha production by human keratinocytes stimulated with gamma interferon in vitro.
    Maruyama K, Zhang JZ, Nihei Y, Ono I, Kaneko F.
    Skin Pharmacol; 1995 Sep 01; 8(1-2):41-8. PubMed ID: 7786524
    [Abstract] [Full Text] [Related]

  • 36. Suppression of NF-kappaB by cyclosporin a and tacrolimus (FK506) via induction of the C/EBP family: implication for unfolded protein response.
    Du S, Hiramatsu N, Hayakawa K, Kasai A, Okamura M, Huang T, Yao J, Takeda M, Araki I, Sawada N, Paton AW, Paton JC, Kitamura M.
    J Immunol; 2009 Jun 01; 182(11):7201-11. PubMed ID: 19454717
    [Abstract] [Full Text] [Related]

  • 37. Cyclosporin A, FK506 and dithranol after tyrosine-specific protein phosphorylation in HaCaT keratinocytes.
    Ockenfels HM, Nussbaum G, Schultewolter T, Burger PM, Goos M.
    Arch Dermatol Res; 1995 Jun 01; 287(3-4):304-9. PubMed ID: 7541191
    [Abstract] [Full Text] [Related]

  • 38. Budesonide, but not tacrolimus, affects the immune functions of normal human keratinocytes.
    Kis K, Bodai L, Polyanka H, Eder K, Pivarcsi A, Duda E, Soos G, Bata-Csorgo Z, Kemeny L.
    Int Immunopharmacol; 2006 Mar 01; 6(3):358-68. PubMed ID: 16428071
    [Abstract] [Full Text] [Related]

  • 39. FK506 independently upregulates transforming growth factor beta and downregulates inducible nitric oxide synthase in cultured human keratinocytes: possible mechanisms of how tacrolimus ointment interacts with atopic skin.
    Lan CC, Kao YH, Huang SM, Yu HS, Chen GS.
    Br J Dermatol; 2004 Sep 01; 151(3):679-84. PubMed ID: 15377358
    [Abstract] [Full Text] [Related]

  • 40. Cyclosporin a and tacrolimus (FK506) differentially alter T-cell receptor expression in vivo.
    Miller JL, Ericson SG.
    Immunopharmacol Immunotoxicol; 2007 Sep 01; 29(1):105-18. PubMed ID: 17464771
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.